课题基金 / 基金详情

项目摘要

项目成果

NILUFER ERTEKIN-TANER的其他基金

相似基金

相关文献

中文摘要
翻译
I.机构职业发展核心:项目总结/摘要 CCaTS KL 2机构职业发展核心的总体目标是提供一流的培训, 能够在多学科合作研究团队中担任领导角色的研究人员, 进行杰出的临床和转化科学。KL 2计划对拥有博士学位的个人开放 在一个适用于临床和转化研究的学科学位,并作为马约现有任命 诊所教员或正在考虑任命马约诊所教员。经过严格的选拔, 成功的申请人及其指导团队根据定义的核心内容制定职业发展计划 临床和转化科学的能力。该计划包括适当的教学培训;经验 和校外学习机会;和一个结构化的,指导翻译研究项目。具体 本次更新申请的目的是1)招募和支持一个不同的学者群体与杰出的 领导多学科,协作团队科学的潜力; 2)提供量身定制的教育经验 基于个人职业发展的需要,包括适当的教学,体验活动, 指导研究经验; 3)培养学者社区,包括与其他职业的伙伴关系 发展计划,无论是在马约诊所和国家。 KL 2计划的主要优势包括计划毕业生作为翻译成功的悠久历史 科学家,教师导师与强大的校外资助的研究项目和记录的多样化池, 指导以前的学者,一个庞大而多样化的候选人库,经过严格的选拔过程,广泛的 免费提供的一系列课程选择,创造积极学习环境的新颖策略, 所有学者,多种网络和社区建设的机会,体验式学习的选择,强大的 为方案完成后向独立过渡提供机构支持,并进行严格的评估 程序. 尽管KL 2 Core有着悠久的成功历史,但我们已经发现了几个改进的机会 通过制定新的计划和修改现有的计划内容, 我们正在进行的严格评估计划的结果。计划中的增强功能包括新的必要学习 团队科学,社交媒体,性别作为生物变量,指导(包括近同行)的经验 级联辅导),隐性课程,包容和发展一个积极的工作环境, 工作人员,并担任访问学者。为学者提供解决这些关键新兴问题的技能 能力将为他们作为CTS调查员的成功做好准备。
英文摘要
I. INSTITUTIONAL CAREER DEVELOPMENT CORE: Project Summary/Abstract The overall objective of the CCaTS KL2 Institutional Career Development Core is to provide superb training to investigators who can assume leadership roles within multidisciplinary collaborative research teams that conduct outstanding clinical and translational science. The KL2 Program is open to individuals with a doctoral degree in a discipline applicable to clinical and translational research and an existing appointment as Mayo Clinic faculty or under consideration for a Mayo Clinic faculty appointment. After a rigorous selection process, successful applicants and their mentoring team formulate a career development plan based on defined core competencies for clinical and translational science. The plan includes appropriate didactic training; experiential and extramural learning opportunities; and a structured, mentored translational research project. The Specific Aims of this renewal application are to 1) recruit and support a diverse group of Scholars with outstanding potential to lead multidisciplinary, collaborative team science; 2) provide tailored educational experiences based on individual career development needs that include appropriate didactics, experiential activities, and a mentored research experience; and 3) foster a community of Scholars, including partnerships with other career development programs, both within Mayo Clinic and nationally. Key strengths of the KL2 Program include a long history of Program graduates having success as translational scientists, a diverse pool of faculty mentors with strong extramurally funded research programs and a record of mentoring prior Scholars, a large and diverse candidate pool subject to a rigorous selection process, a wide range of curricular options offered without charge, novel strategies to create a positive learning environment for all Scholars, multiple networking and community-building opportunities, options for experiential learning, strong institutional support for the transition to independence after Program completion, and a rigorous evaluation program. Although the KL2 Core has a long history of success, we have identified several opportunities for improvement and innovation, both by crafting new initiatives and by modifying existing program elements as guided by the results of our ongoing rigorous evaluation program. Planned enhancements include new required learning experiences in team science, social media, sex as a biological variable, mentoring (including near-peer cascading mentorship), the hidden curriculum, inclusion and developing a positive working environment for staff, and acting as a visiting scholar. Equipping Scholars with skills addressing these key emerging competencies will prepare them for success as CTS investigators.
期刊论文(174)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1177/08850666211069098
发表时间: 2022-08
期刊: Journal of intensive care medicine
影响因子: 3.1
作者: []
通讯作者:
Genetic predictors of chemotherapy-related amenorrhea in women with breast cancer.
乳腺癌女性化疗相关闭经的遗传预测因素。
DOI: 10.1016/j.fertnstert.2019.05.018
发表时间: 2019
期刊: Fertility and sterility
影响因子: 6.7
作者: [Ruddy,KathrynJ, Schaid,DanielJ, Partridge,AnnH, Larson,NicholasB, Batzler,Anthony, Häberle,Lothar, Dittrich,Ralf, Widschwendter,Peter, Fink,Visnja, Bauer,Emanuel, Schwitulla,Judith, Rübner,Matthias, Ekici,ArifB, Aivazova-Fuchs,Viktoria, ]
通讯作者:
Intraoperative Plasma Transfusion Volumes and Outcomes in Cardiac Surgery.
心脏手术中的术中血浆输注量和结果。
DOI: 10.1053/j.jvca.2019.12.049
发表时间: 2020
期刊: Journal of cardiothoracic and vascular anesthesia
影响因子: 2.8
作者: [Smith,MarkM, Kor,DarylJ, Frank,RyanD, Weister,TimothyJ, Dearani,JosephA, Warner,MatthewA]
通讯作者: Warner,MatthewA
Oxybutynin vs Placebo for Hot Flashes in Women With or Without Breast Cancer: A Randomized, Double-Blind Clinical Trial (ACCRU SC-1603).
奥昔布宁与安慰剂治疗患有或不患有乳腺癌的女性潮热:一项随机、双盲临床试验 (ACCRU SC-1603)。
DOI: 10.1093/jncics/pkz088
发表时间: 2020
期刊: JNCI cancer spectrum
影响因子: 4.4
作者: [Leon-Ferre,RobertoA, Novotny,PaulJ, Wolfe,EricG, Faubion,StephanieS, Ruddy,KathrynJ, Flora,Daniel, Dakhil,ChristopherSR, Rowland,KendrithM, Graham,MarkL, Le-Lindqwister,Nguyet, Smith,ThomasJ, Loprinzi,CharlesL]
通讯作者: Loprinzi,CharlesL
共 100 条
    Discovering Centrally Linked Peripheral Molecular Signatures of Alzheimer's Disease
    • 批准号:
      10555727
    • 项目类别:
    • 资助金额:
      $97.58万
    • 财政年份:
      2023
    • 负责人:
      NILUFER ERTEKIN-TANER
    • 依托单位:
    Administrative Core
    • 批准号:
      10555724
    • 项目类别:
    • 资助金额:
      $52.77万
    • 财政年份:
      2023
    • 负责人:
      NILUFER ERTEKIN-TANER
    • 依托单位:
    A Systems Approach to Targeting Innate Immunity in AD
    • 批准号:
      10246077
    • 项目类别:
    • 资助金额:
      $323.37万
    • 财政年份:
      2020
    • 负责人:
      NILUFER ERTEKIN-TANER
    • 依托单位:
    Integrating the exposome and methylome to inform brain molecular changes in ADRD across established diverse cohorts.
    • 批准号:
      10657846
    • 项目类别:
    • 资助金额:
      $98.9万
    • 财政年份:
      2020
    • 负责人:
      NILUFER ERTEKIN-TANER
    • 依托单位:
    海外基金